The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter retrospective analysis for efficacy and safety of liposomal irinotecan (nal-IRI) plus 5-FU/leucovorin (5-FU/LV) after progression on gemcitabine-based therapy in Korean patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A study by Korean cancer study group (KCSG).
 
Changhoon Yoo
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - LSK BioPharma
Speakers' Bureau - Bayer; Celgene; Ipsen
 
Hyeon-Su Im
No Relationships to Disclose
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech
 
Do-Youn Oh
No Relationships to Disclose
 
Kyung-Hun Lee
No Relationships to Disclose
 
Hong Jae Chon
No Relationships to Disclose
 
Joo Hoon Kim
No Relationships to Disclose
 
Myoung Joo Kang
No Relationships to Disclose
 
Il-Hwan Kim
No Relationships to Disclose
 
Guk Jin Lee
No Relationships to Disclose
 
Sung Yong Oh
No Relationships to Disclose
 
Younak Choi
No Relationships to Disclose
 
Hye Jin Choi
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Joon Oh Park
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene; Celgene; Celgene
Research Funding - AstraZeneca; Celgene
 
Baek-Yeol Ryoo
No Relationships to Disclose